- Home
- MNOV vs ALPS Comparison
MNOV vs ALPS Comparison
Compare MNOV & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNOV | ALPS |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.4M | 77.6M |
| IPO Year | 2004 | 2024 |
Fundamental Metrics
Financial Performance| Metric | MNOV | ALPS |
|---|---|---|
| Price | $1.79 | $0.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 46.9K | ★ 70.9K |
| Earning Date | 05-14-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,360,807.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $180.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.17 | $0.23 |
| 52 Week High | $1.96 | $1.72 |
Technical Indicators
Market Signals| Indicator | MNOV | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 77.94 | 47.28 |
| Support Level | $1.28 | $0.23 |
| Resistance Level | $1.80 | $0.43 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 87.00 | 74.00 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
About ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.